ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1074

A Meta-Analysis of the Risk of Venous Thromboembolism in Inflammatory Rheumatic Diseases

Jason J Lee1 and Janet E. Pope2, 1Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, 2St Joseph Health Care, London, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Connective tissue diseases, inflammatory arthritis, meta-analysis, thrombosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis and Systemic Lupus Erythematosus Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose:

We performed a meta-analysis investigating the risk of developing deep vein thrombosis (DVT) and/or pulmonary embolisms (PE) in patients with inflammatory arthritis, vasculitis, and connective tissue diseases (CTD) [SLE, Sjogren’s syndrome, inflammatory myositis and systemic sclerosis (SSc)].

Methods:

PubMed, Embase, Cochrane Databases, and Medline were searched identifying full text English publications in adults related to rheumatologic inflammatory diseases and VTE. Data regarding rates of DVTs and PEs were extracted. Using random effects models, pooled estimates for VTE in individual and pooled diseases compared with matched populations where possible. Studies were excluded if VTEs were in the setting of pregnancy, postoperative outcomes or solely antiphospholipid antibody syndrome.

Results:

Most of the 3,929 studies were excluded due to lack of rate or incidence of VTE. Twenty studies remained for analysis. Eight studies of RA identified 5,273,942 patients and 891,530,181 controls with a cumulative incidence of 2.18% (95% CI: 1.82–2.54%) and an odds ratio of 2.23 (95% CI: 2.02–2.47) compared to age and sex, matched population. Six studies included 36,582 SLE patients with a cumulative incidence of 8.24% (95% CI: 6.27–10.22%); three Sjogren’s syndrome studies (N=16,180) demonstrated a VTE cumulative incidence of 2.62% (95% CI: 2.15–3.10%); four studies of inflammatory myositis (N=8,245) yielded a VTE cumulative incidence of 4.03% (95% CI: 2.38–5.67%), SSc and ANCA vasculitis rates (3 studies each) were 3.82% and 8.51% respectively. The figure shows VTEs in RA as an example.

Conclusion:

Inflammatory rheumatologic diseases studied were all associated with high rates of VTEs, more nearly three times higher than the general population. Identification of those at risk is important. We cannot determine from these studies what the risk is when inflammation is effectively treated.

Macintosh HD:Users:Janet:Desktop:Active papers:ACR 2014 Boston:Janets submitted abstracts ACR Boston 2014:xxxxxxJason for ACR abstract figure to add.jpg


Disclosure:

J. J. Lee,
None;

J. E. Pope,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-meta-analysis-of-the-risk-of-venous-thromboembolism-in-inflammatory-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology